Unleashing Canada's radiopharmaceutical excellence

(PR Associates) The Centre for Probe Development and Commercialization (CPDC) and adMare BioInnovations (adMare) are pleased to announce they have formed a new collaboration, " The CPDC-adMare Radiopharmaceutical Initiative (CARI) " to bring their respective resources together to advance an area of tremendous therapeutic and commercial potential in which Canada can gain a considerable global competitive advantage: radiopharmaceuticals. This field revolutionized precision medicine by the use of theranostics where targeted therapies are combined with diagnosis, treatment planning, drug delivery, and response assessment to improve cancer patient outcomes.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news